CAD (p. Arg 2024 Gln) mutation with loss function of carbamoyl–phosphate binding, causes developmental delays and epileptic encephalopathy, which implicates that CAD deficiency is linked tightly with neurometabolic disorders. The gene discussed is CAD; the disease is Epileptic encephalopathy.